New Academy team ensures bright future in research and clinical education at Heidelberg Engineering

New Academy TeamHemel Hempstead, United Kingdom – The Director of Clinical Affairs at Heidelberg Engineering Limited, Christopher Mody, has accepted a new position as Clinical Director with Heidelberg Engineering GmbH. In his new global role, Chris will work closely with the global Product Management and Clinical Affairs team members to foster collaborative relationships with key opinion leaders and facilitate the exchange of unbiased scientific information between the international medical community and the company.

In light of this change, the management team at Heidelberg Engineering Limited has been reorganised to ensure that the Academy and the company’s involvement at the forefront of research in ophthalmic imaging continues to be carefully managed and nurtured. Tim Cole has been promoted to Clinical Affairs Manager, providing the company with clinical direction and feedback that will help to shape product development and research activity. Emily Malbon has been promoted to Head of UK Marketing and Education, managing the Academy team and ensuring the company continues to deliver high-quality education to the industry that is innovative and relevant.

Both Emily and Tim have advanced progressively during their time at Heidelberg Engineering, playing a crucial role in clinical education globally”, explains Tosh Vadhia, General Manager, Heidelberg Engineering Limited. “They are both avid learners, determined individuals, and bring a wealth of experience to their new positions. I would like to say a huge thank you to Chris for his work and commitment towards Heidelberg Engineering UK. It has been pleasure working closely with Chris over the last few years and we are so pleased that the global company will now formally benefit from his clinical expertise and counsel”.

If you wish to contact Heidelberg Engineering about clinical matters, please email where the team will ensure your enquiry is dealt with promptly.

back to overview